Detalhe da pesquisa
1.
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
J Neurooncol
; 163(2): 327-338, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237151
2.
Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 24(13)2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445722
3.
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Br J Cancer
; 127(3): 488-499, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501389
4.
AMPK-regulated miRNA-210-3p is activated during ischaemic neuronal injury and modulates PI3K-p70S6K signalling.
J Neurochem
; 159(4): 710-728, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694332
5.
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer.
J Transl Med
; 19(1): 184, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933113
6.
Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenograft models of metastatic colorectal cancer.
Int J Cancer
; 147(10): 2891-2901, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700762
7.
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
J Transl Med
; 18(1): 99, 2020 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087721
8.
Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A.
Invest New Drugs
; 38(5): 1365-1372, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318883
9.
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.
Cancer Cell Int
; 19: 10, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636931
10.
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro.
BMC Cancer
; 18(1): 168, 2018 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29426295
11.
BCL-2 system analysis identifies high-risk colorectal cancer patients.
Gut
; 66(12): 2141-2148, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27663504
12.
Stratification of clear cell renal cell carcinoma by signaling pathway analysis.
Expert Rev Proteomics
; 11(2): 237-49, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24575852
13.
Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development.
Cancer Gene Ther
; 30(2): 324-334, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266450
14.
Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer.
Cancer Biol Ther
; 24(1): 2223388, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326340
15.
A Systems Biology Approach to Investigate Kinase Signal Transduction Networks That Are Involved in Triple Negative Breast Cancer Resistance to Cisplatin.
J Pers Med
; 12(8)2022 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36013226
16.
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression.
Cancers (Basel)
; 14(5)2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267611
17.
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
Ther Adv Med Oncol
; 12: 1758835919897546, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064003
18.
Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea.
J Mol Med (Berl)
; 98(1): 149-159, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848663
19.
In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6.
Int J Oncol
; 34(4): 1099-108, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19287968
20.
Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate.
Proteomics Clin Appl
; 13(4): e1800159, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768761